BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. (Q44582243)
Jump to navigation
Jump to search
scientific article published on 11 September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. |
scientific article published on 11 September 2003 |
Statements
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients (English)
Rowena D Faulkner
Prem Mahendra
Andrew P Haynes
Hugh G Prentice
Michael Potter
Aloysius Ho
Grant McQuaker
Ghulam Mufti
John Liu Yin
Nigel H Russell
11 September 2003